Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Ironwood Pharmaceuticals Inc., 3 years.
Ironwood Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Ironwood Pharmaceuticals Inc. | Grant or award | +63,481 | — | — |
| Jun 15, 2026 | Ironwood Pharmaceuticals Inc. | Grant or award | +4,065 | — | — |
| Mar 17, 2026 | Ironwood Pharmaceuticals Inc. | Open-market sale | −6,725,000 | $3.05 | $20,511,250 |
| Mar 17, 2026 | Ironwood Pharmaceuticals Inc. | Open-market sale | −5,800 | $3.31 | $19,198 |
| Mar 13, 2026 | Ironwood Pharmaceuticals Inc. | Grant or award | +4,451 | — | — |
| Dec 15, 2025 | Ironwood Pharmaceuticals Inc. | Grant or award | +4,178 | — | — |
| Sep 15, 2025 | Ironwood Pharmaceuticals Inc. | Grant or award | +11,718 | — | — |
| Jun 13, 2025 | Ironwood Pharmaceuticals Inc. | Grant or award | +24,193 | — | — |
| Jun 10, 2025 | Ironwood Pharmaceuticals Inc. | Grant or award | +45,000 | — | — |
| Apr 2, 2025 | Ironwood Pharmaceuticals Inc. | Grant or award | +10,416 | — | — |
| Mar 6, 2025 | Innoviva Inc. | Open-market sale | −1,196,746 | $17.52 | $20,966,990 |
| Mar 5, 2025 | Innoviva Inc. | Open-market sale | −270,374 | $17.63 | $4,766,694 |
| Mar 4, 2025 | Innoviva Inc. | Open-market sale | −151,175 | $17.63 | $2,665,215 |
| Dec 16, 2024 | Ironwood Pharmaceuticals Inc. | Grant or award | +4,249 | — | — |
| Sep 16, 2024 | Ironwood Pharmaceuticals Inc. | Grant or award | +3,282 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.